Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients
Authors
Keywords
Metabolic volume, Lymphoma, Prognosis, PET/CT
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 41, Issue 6, Pages 1113-1122
Publisher
Springer Nature
Online
2014-02-25
DOI
10.1007/s00259-014-2705-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma
- (2013) Moo-Kon Song et al. CANCER SCIENCE
- Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours
- (2012) Christophe Van de Wiele et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapy
- (2012) Paolo G Gobbi et al. HEMATOLOGICAL ONCOLOGY
- Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement
- (2011) Moo-Kon Song et al. ANNALS OF HEMATOLOGY
- SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
- (2011) R.-O. Casasnovas et al. BLOOD
- Prognostic value of metabolic tumor volume on PET / CT in primary gastrointestinal diffuse large B cell lymphoma
- (2011) Moo-Kon Song et al. CANCER SCIENCE
- CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
- (2011) Michael Pfreundschuh et al. LANCET ONCOLOGY
- Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern Italy
- (2011) Stefano Luminari et al. LEUKEMIA & LYMPHOMA
- Comparative Assessment of Methods for Estimating Tumor Volume and Standardized Uptake Value in 18F-FDG PET
- (2010) P. Tylski et al. JOURNAL OF NUCLEAR MEDICINE
- Repeatability of Metabolically Active Volume Measurements with 18F-FDG and 18F-FLT PET in Non-Small Cell Lung Cancer
- (2010) V. Frings et al. JOURNAL OF NUCLEAR MEDICINE
- FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
- (2009) Ronald Boellaard et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
- (2009) R. L. Wahl et al. JOURNAL OF NUCLEAR MEDICINE
- Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma
- (2008) C. Bodet-Milin et al. HAEMATOLOGICA
- Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study
- (2008) Michael Pfreundschuh et al. LANCET ONCOLOGY
- Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET
- (2008) Arnold Berkowitz et al. NUCLEAR MEDICINE COMMUNICATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now